Gba-L462P

Nomenclature

C57BL/6JSmo-Gbaem(L462P)Smoc

Cat. NO.

NM-KI-225100

Strain State

Repository Live

Export PDF

Model Description

These mice carry a L462P mutation of Gba gene.

Validation Data

f9529f8c-cd4d-40e1-85d1-bed7bcbc39c9.png

Fig.1 Detection of Gba expression in liver, spleen and brain by RT-PCR. Mouse Gba mRNA (432 bp) and mouse Gapdh mRNA (123 bp) was detectable both in wild-type C57BL/6 mice and heterozygous Gba-L462P mice. Liver, spleen and brain RNA was extracted from 32-week-old male wild-type C57BL/6 (WT)(n=2) and heterozygous Gba-L462P mice (HE) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.

Abbr. M, marker; HE, heterozygous; WT, wild type.

f1b902a1-b50a-4975-a3f7-ebd0e137a5d1.png

Fig.2 mRNA sequencing of Gba-L462P knockin mice. Sequencing data of RT-PCR products confirmed the presence of target mutations in Gba-L462P mice.

Abbr. HE, heterozygous; WT, wild type.

32efd016-66d3-4b9c-95aa-6b7c58e1059f.png

Fig.3 Detection of GC activity expression in liver homogenate of WT C57BL/6 mice and HE Gba-L462P mice by ELISA. GC activity was detectable in liver homogenate from both WT C57BL/6 and heterozygote Gba-L462P knockin mice. Liver tissues lysates were collected from wild-type C57BL/6 mice (n=3, male, 34 weeks old) and HE Gba-L462P mice (n=3, male, 34 weeks old), and analyzed by ELISA with Glucosylceramidase Activity ELISA kit.

Abbr.  HE, heterozygote; WT, wild type; GC, Glucosylceramidase.

62f754de-837e-4299-b5a5-f0dc1a79f7c1.png

Fig.4 Detection of GC activity expression in spleen homogenate of WT C57BL/6 mice and HE Gba-L462P mice by ELISA. GC activity was detectable in spleen homogenate from both WT C57BL/6 and heterozygote Gba-L462P knockin mice.Spleen tissues lysates were collected from wild-type C57BL/6 mice (n=3, male, 34 weeks old) and HE Gba-L462P mice (n=3, male, 34 weeks old), and analyzed by ELISA with Glucosylceramidase Activity ELISA kit.

Abbr.  HE, heterozygote; WT, wild type; GC, Glucosylceramidase.

image.png

Fig.5 Detection of GC activity expression in brain homogenate of WT C57BL/6 mice and HE Gba-L462P mice by ELISA. GC activity was detectable in brain homogenate from both WT C57BL/6 and heterozygote Gba-L462P knockin mice. Brain tissues lysates were collected from wild-type C57BL/6 mice (n=3, male, 34 weeks old) and HE Gba-L462P mice (n=3, male, 34 weeks old), and analyzed by ELISA with Glucosylceramidase Activity ELISA kit.

Abbr.  HE, heterozygote; WT, wild type; GC, Glucosylceramidase.

166ad649-f17a-4f4c-9da8-15f14b511753.png

Fig. 6 Detection of α-Synuclein expression in the substantia nigra of Gba-L462P mice by IHC. α-Synuclein immunoreactivity was detectable in the substantia nigra of both WT C57BL/6 and heterozygous Gba-L462P mice. Representative images of α-synuclein staining in the substantia nigra of WT C57BL/6 mice (left) and heterozygous Gba-L462P mice (right) (n = 2 males).

Abbr. HE, heterozygous; WT, wild type.


You may also like

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more